KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Current Deferred Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Current Deferred Revenue for 14 consecutive years, with $517000.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 79.51% to $517000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $517000.0 through Dec 2025, down 79.51% year-over-year, with the annual reading at $517000.0 for FY2025, 79.51% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $517000.0 at Precigen, down from $575000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $26.9 million in Q1 2021, with the low at $15000.0 in Q2 2023.
  • Average Current Deferred Revenue over 5 years is $8.6 million, with a median of $2.2 million recorded in 2024.
  • The sharpest move saw Current Deferred Revenue crashed 99.94% in 2023, then soared 14540.0% in 2024.
  • Over 5 years, Current Deferred Revenue stood at $24.5 million in 2021, then crashed by 99.9% to $25000.0 in 2022, then skyrocketed by 1936.0% to $509000.0 in 2023, then skyrocketed by 395.68% to $2.5 million in 2024, then crashed by 79.51% to $517000.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $517000.0, $575000.0, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.